🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The brilliant light of our family has dimmed his light for us in the present world,” his relatives stated. “After a lengthy and brave battle with cancer, we are heartbroken to announce that Michael D’Angelo Archer, known to his followers around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative modern soul style and collaborations with high-profile artists.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album reached No. 4 on Billboard’s Top R&B Albums chart, earned platinum status soon after, and received several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his artistic journey into the limelight. The album debuted at the top spot on each of the R&B charts and the Billboard 200. He won two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the cultural zeitgeist. The personal depiction showed the artist, famously bare to his midsection, performing directly into the lens.

D’Angelo stepped back from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious vehicle accident that left him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with a further No. 1 debut on the soul music rankings and a Grammy for Best R&B Album.

Once more, in his own mysterious way, D’Angelo had limited public outings in the subsequent period.

The musician was announced as a top act for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s well-being in the months before his death, he had reportedly been hospitalized for months and in palliative care for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the deadliest and hardest to prevent forms of the illness, on a brilliant talent whose existence was ended too soon.

“We are grieved that he can only provide dear memories with his family, but we are eternally grateful for the heritage of extraordinarily moving songs he has left us,” his kin expressed.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a tiny gland that produces the hormone insulin and is vital in digestion, among other functions. The size and location of the organ in the human system make it more challenging to detect cancer.

Even though this cancer makes up only about 3% of cancer diagnoses annually in the U.S., it is causes seven percent of cancer deaths.

Nearly 70,000 people will be found to have this condition and about 52,000 will succumb to the illness in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and dismal outcomes. We have limited and poor treatment options, and a smaller window to make a meaningful impact on the lives of people,” said a cancer specialist.

Since pancreatic cancer rarely causes initial signs, it’s frequently identified only once the condition is advanced. Even when a patient has indicators they are usually nonspecific and may be mistaken for a number of everyday ailments.

“As of yet, there is no effective method to detect this malignancy in the early stages, apart from listening to your body and consulting your physician if there are new or unusual symptoms,” said a medical director.

Common symptoms of this disease encompass:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• reduced hunger
• dark urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an exception, as pancreatic cancer is most common in individuals in the 65 to 75 age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent among younger people.

“Pancreatic cancer identified before the age of 50 is deemed uncommon, yet alarmingly, doctors are noticing a rising count of younger patients suffering from this condition,” said a expert.

Genetic Background Impacts Cancer Risk

Without effective screening tools for this malignancy, professionals stressed the significance of knowing your family’s health background. Certain risk factors, such as smoking and obesity also have an influence in the development of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are more prone to be diagnosed with inoperable cancer.

“The initial action toward reducing one’s chance of pancreatic cancer is assessing individual susceptibility. People should review their family history, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or overweight that may increase their vulnerability,” said a medical professional.

Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If a relative in your family has had pancreatic cancer, you may want to think about genetic testing.

“For individuals with a relative’s background of this condition or those carrying elevated risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find early changes in the pancreas,” he explained.

For those looking to reduce their risk, lifestyle changes may have an effect. The best action you can take to lower your risk of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so limiting or avoiding alcohol may assist reduce your risk.

Managing your body mass or losing weight may also aid reduce your risk. Individuals with excess weight are twenty percent more prone to develop this disease. This malignancy also is more frequent in those with blood sugar issues, and weight loss can also lower the chance of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and more recent combination chemotherapy. There are emerging targeted therapies that are already showing results,” said a expert.

For many individuals, however, awareness about this uncommon but {dev